Rockwell Medical's ROE % for the quarter that ended in Mar. 2026 was -17.63%. Rockwell Medical's PB Ratio for the quarter that ended in Mar. 2026 was 0.98.
Rockwell Medical's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 was -17.99%.
Rockwell Medical ROE % Adjusted to Book Value Related Terms
Rockwell Medical ROE % Adjusted to Book Value Historical Data
* Premium members only.
The historical data trend for Rockwell Medical's ROE % Adjusted to Book Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Rockwell Medical ROE % Adjusted to Book Value Chart
RMTI vs CPHI, TXMD, MRMD: ROE % Adjusted to Book Value Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Rockwell Medical's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Rockwell Medical ROE % Adjusted to Book Value vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Rockwell Medical's ROE % Adjusted to Book Value distribution charts can be found below:
* The bar in red indicates where Rockwell Medical's ROE % Adjusted to Book Value falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROE % Adjusted to Book Value of -17.99% mean?
Rockwell Medical (RMTI) has a ROE % Adjusted to Book Value of -17.99% as of Mar. 2026. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Rockwell Medical and its competitors.
Is Rockwell Medical's ROE % Adjusted to Book Value too high?
Rockwell Medical's current ROE % Adjusted to Book Value is -17.99%. Overall, Rockwell Medical has a GF Score™ of 30/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Rockwell Medical's ROE % Adjusted to Book Value compare to CPHI and TXMD?
Rockwell Medical's ROE % Adjusted to Book Value of -17.99% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Drug Manufacturers company?
A good ROE % Adjusted to Book Value depends on the Drug Manufacturers industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Rockwell Medical and its competitors. Rockwell Medical's current ROE % Adjusted to Book Value is -17.99%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rockwell Medical stock overvalued right now?
Based on GuruFocus' analysis, Rockwell Medical (RMTI) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.87, compared to a current price of $5.19 — trading 496.6% above its estimated fair value. The current ROE % Adjusted to Book Value is -17.99%. Rockwell Medical's overall GF Score™ is 30/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Rockwell Medical (RMTI), the current ROE % Adjusted to Book Value is -17.99% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Rockwell Medical (RMTI) Overvalued in 2026?
Based on GuruFocus' analysis, Rockwell Medical stock appears to be overvalued.
The current stock price of $5.19 is trading 496.6% above its estimated GF Value™ of $0.87.
GuruFocus considers Rockwell Medical to be Significantly Overvalued.
Key valuation signals for RMTI:
ROE % Adjusted to Book Value: -17.99%
GF Value™: $0.87 vs. price of $5.19 (496.6% above fair value)
No single metric tells the full story. See the RMTI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, acid, and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate, among others. The company delivers the majority of its hemodialysis concentrates products and mixers to dialysis clinics throughout the United States and internationally, utilizing its own delivery trucks and third-party carriers.
30GF Score
Get the complete analysis for RMTI
ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
RMTI has been successfully added to your 
